ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Details

Serval ID
serval:BIB_2627DC6163D3
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
Journal
Journal of the European Academy of Dermatology and Venereology
Author(s)
Cerminara S.E., Cvijetic I., Huber S., Müller S., Kostner L., Goessinger E.V., Narainsing J., Dutilh G., Heidemeyer K., Yawalkar N., Conrad C., Plaza T., Maul J.T., Cozzio A., Navarini A.A.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
In Press
Peer-reviewed
Oui
Language
english
Notes
Publication types: Letter
Publication Status: aheadofprint
Pubmed
Web of science
Open Access
Yes
Create date
28/10/2024 15:00
Last modification date
22/11/2024 17:55
Usage data